TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 29 filers reported holding TSCAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,301,949 | +36.2% | 1,680,449 | +33.0% | 0.00% | – |
Q2 2023 | $3,158,634 | -0.7% | 1,263,453 | -16.6% | 0.00% | – |
Q1 2023 | $3,181,604 | +35.6% | 1,515,050 | +0.1% | 0.00% | – |
Q4 2022 | $2,346,616 | -49.2% | 1,513,946 | +0.0% | 0.00% | – |
Q3 2022 | $4,617,000 | -3.1% | 1,513,815 | -0.1% | 0.00% | – |
Q2 2022 | $4,765,000 | +12.0% | 1,514,964 | -0.3% | 0.00% | – |
Q1 2022 | $4,254,000 | -36.9% | 1,519,188 | +1.4% | 0.00% | – |
Q4 2021 | $6,744,000 | -46.1% | 1,498,538 | -0.1% | 0.00% | – |
Q3 2021 | $12,515,000 | – | 1,500,577 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DC Funds, LP | 630,000 | $1,323,000 | 30.82% |
Deer Management Co. LLC | 1,245,505 | $2,615,561 | 0.24% |
Simplify Asset Management Inc. | 546,916 | $1,148,524 | 0.16% |
Alphabet Inc. | 1,077,080 | $2,261,868 | 0.12% |
Newtyn Management, LLC | 236,800 | $497,280 | 0.10% |
DC Investments Management, LLC | 35,563 | $74,682 | 0.09% |
Privium Fund Management (UK) Ltd | 15,825 | $40,987 | 0.03% |
Baker Brothers Advisors | 2,784,792 | $5,848,063 | 0.03% |
Tekla Capital Management LLC | 200,000 | $420,000 | 0.02% |
NewEdge Wealth, LLC | 91,463 | $192,072 | 0.01% |